Marshall Wace LLP Makes New $4.94 Million Investment in Innospec Inc. (NASDAQ:IOSP)

Marshall Wace LLP bought a new stake in shares of Innospec Inc. (NASDAQ:IOSP) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 39,992 shares of the specialty chemicals company’s stock, valued at approximately $4,943,000.

Several other large investors have also recently made changes to their positions in the business. UBS Group AG increased its position in Innospec by 204,935.7% during the 4th quarter. UBS Group AG now owns 57,410 shares of the specialty chemicals company’s stock valued at $7,075,000 after buying an additional 57,382 shares in the last quarter. TFO Wealth Partners LLC increased its holdings in shares of Innospec by 29,800.0% during the fourth quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after acquiring an additional 298 shares in the last quarter. Campbell & CO Investment Adviser LLC purchased a new position in shares of Innospec in the 4th quarter worth about $504,000. Vanguard Group Inc. raised its position in shares of Innospec by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 2,953,918 shares of the specialty chemicals company’s stock worth $364,041,000 after purchasing an additional 12,562 shares during the last quarter. Finally, Los Angeles Capital Management LLC boosted its stake in Innospec by 11.1% in the 1st quarter. Los Angeles Capital Management LLC now owns 3,651 shares of the specialty chemicals company’s stock worth $471,000 after purchasing an additional 364 shares in the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.

Innospec Stock Down 0.8 %

Shares of NASDAQ IOSP opened at $112.21 on Wednesday. The firm has a market cap of $2.80 billion, a P/E ratio of 19.06 and a beta of 1.08. Innospec Inc. has a twelve month low of $95.69 and a twelve month high of $133.71. The company has a 50 day moving average of $113.94 and a 200 day moving average of $121.25.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.02. The business had revenue of $435.00 million during the quarter, compared to analyst estimates of $468.73 million. Innospec had a return on equity of 14.15% and a net margin of 7.90%. The company’s quarterly revenue was down 9.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.28 EPS. As a group, equities analysts expect that Innospec Inc. will post 5.95 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Innospec news, CFO Ian Cleminson sold 6,602 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $113.60, for a total transaction of $749,987.20. Following the transaction, the chief financial officer now owns 16,394 shares in the company, valued at approximately $1,862,358.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.52% of the stock is owned by insiders.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.